A near-infrared fluorescent probe specifically targeting a beta amyloid 42 and a preparation method and application thereof
By designing a near-infrared fluorescent probe specifically targeting A42, and utilizing conjugated structure and intramolecular charge transfer, highly selective fluorescence imaging of A42 aggregates is achieved, solving the problem of difficulty in distinguishing A40 and A42 in existing technologies, and providing an effective tool for AD pathology research.
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- THE FIRST AFFILIATED HOSPITAL ZHEJIANG UNIV COLLEGE OF MEDICINE
- Filing Date
- 2026-04-27
- Publication Date
- 2026-07-07
AI Technical Summary
Existing technologies struggle to accurately distinguish between A40 and A42, limiting our understanding of the mechanism of A plaque action in the pathological process of Alzheimer's disease. Furthermore, small molecule probes with this ability to differentiate between them are scarce.
A near-infrared fluorescent probe specifically targeting A42 was designed. Through its extended conjugated structure and strong intramolecular charge transfer, near-infrared fluorescence emission was achieved. Combined with in vitro spectroscopy experiments and tissue section staining, it provides high selectivity and co-localization effect for A42 aggregates.
It achieves high selectivity and near-infrared luminescence capability for A42 aggregates, strong microscopic imaging capability, and efficient staining in both in vivo and ex vivo tissue sections, providing a tool for the diagnosis of AD disease. Moreover, the preparation method is simple, low-cost, and easy to control.
Smart Images

Figure CN122079978B_ABST